3-184032870-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001163646.2(HTR3D):c.40C>G(p.Leu14Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001163646.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HTR3D | NM_001145143.1 | c.66+1063C>G | intron_variant | ENST00000428798.7 | NP_001138615.1 | |||
HTR3D | NM_001163646.2 | c.40C>G | p.Leu14Val | missense_variant | 1/8 | NP_001157118.1 | ||
HTR3D | NM_182537.3 | c.-198+1299C>G | intron_variant | NP_872343.2 | ||||
HTR3D | NM_001410851.1 | c.-164+1299C>G | intron_variant | NP_001397780.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HTR3D | ENST00000382489.3 | c.40C>G | p.Leu14Val | missense_variant | 1/8 | 1 | ENSP00000371929.3 | |||
HTR3D | ENST00000428798.7 | c.66+1063C>G | intron_variant | 5 | NM_001145143.1 | ENSP00000405409.2 | ||||
HTR3D | ENST00000334128.6 | c.-198+1299C>G | intron_variant | 1 | ENSP00000334315.2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | The c.40C>G (p.L14V) alteration is located in exon 1 (coding exon 1) of the HTR3D gene. This alteration results from a C to G substitution at nucleotide position 40, causing the leucine (L) at amino acid position 14 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.